The Born in Guangzhou Cohort Study (BIGCS)

Recruiting Observational Study
Intrauterine Hyperglycemia Pregnancy Outcomes Neurodevelopment Immune Development Childhood Obesity Host and Microbiome
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
30,000 (estimated)
Sponsor
Guangzhou Women and Children's Medical Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The Born in Guangzhou Cohort Study (BIGCS) was established to investigate the short- and long-term effects of exposure in early life on health consequences in Guangzhou, China. Data are collected regarding environmental, occupational and lifestyle exposures as well as health outcomes in later life. Biological samples including blood and tissue samples are also collected from the participants.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Pregnant women with \<20 weeks of gestation * Pregnant women intended to eventually deliver in Guangzhou Women and Children's Medical Center * Permanent residents or families intended to remain in Guangzhou with their child for ≥3 years
Contacts

Xiu Qiu, PhD

0086 20 38367160

qxiu0161@163.com

CONTACT

Jianrong He, MS

0086 20 38367159

hjr0703@163.com

CONTACT